Nakamura Kohei, Nakayama Kentaro, Ishikawa Masako, Katagiri Hiroshi, Ishibashi Tomoka, Sato Emi, Amano Chika, Kyo Satoru
Department of Obstetrics and Gynecology, Shimane University School of Medicine, Izumo, Shimane 6938501, Japan.
Department of Organ Pathology, Shimane University School of Medicine, Izumo, Shimane 6938501, Japan.
Oncol Lett. 2016 May;11(5):3025-3027. doi: 10.3892/ol.2016.4374. Epub 2016 Mar 23.
Microwave endometrial ablation (MEA) is effective for the emergency control of uterine hemorrhage. However, to the best of our knowledge, there has been only a single report of life-threatening hemorrhage induced by endometrial carcinoma that was treated with MEA. The present report evaluates the efficacy of MEA as an emergency therapeutic option for the control of bleeding due to advanced endometrial carcinoma and minimally-invasive, early-stage endometrial carcinoma in 3 patients. MEA was able to effectively control massive uterine bleeding due to endometrial carcinoma in 2 patients with advanced disease and was curative in a patient with minimally-invasive endometrial carcinoma. Given its safety, simplicity and effectiveness, MEA may be utilized for the emergency treatment of uterine bleeding in advanced endometrial carcinoma, and may be used as a curative treatment in early-stage endometrial carcinoma.
微波子宫内膜消融术(MEA)对子宫出血的紧急控制有效。然而,据我们所知,仅有一份关于用MEA治疗子宫内膜癌引起的危及生命出血的报告。本报告评估了MEA作为紧急治疗选择,用于控制3例晚期子宫内膜癌和微创早期子宫内膜癌所致出血的疗效。MEA能够有效控制2例晚期疾病患者因子宫内膜癌引起的大量子宫出血,并治愈了1例微创子宫内膜癌患者。鉴于其安全性、简便性和有效性,MEA可用于晚期子宫内膜癌子宫出血的紧急治疗,也可用于早期子宫内膜癌的根治性治疗。